Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia
about
The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatmentsMetabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkersBetaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational StudyAssessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patientsMetabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitusVariability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.Betaine: a key modulator of one-carbon metabolism and homocysteine status.Functional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells.Acute inhibition of the betaine transporter by ATP and adenosine in renal MDCK cells.Down-regulated miR-15a mediates the epithelial-mesenchymal transition in renal tubular epithelial cells promoted by high glucose.Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin.Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.Effect of ATP on Ca2+ uptake in the presence of high glucose in renal proximal tubule cells.Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period.Betaine in Inflammation: Mechanistic Aspects and Applications.
P2860
Q28481369-BB37A6D2-7475-4622-9186-049AF1405A40Q28481662-A31FA970-E5B6-45B3-A66B-B66FB45F9ACFQ34672965-4EF177C2-54DC-4006-BDAC-9BB7432368B1Q34924389-6F498CBB-0496-4E94-A2DF-58CD810DE036Q35010970-B8A0F134-C34E-4C92-AF44-0865B40636FCQ36091635-8C75F976-A3B3-4891-BFD2-7AA753A916DCQ36273334-06B19133-5D12-4039-8297-C8B24B9D2469Q36309350-503A33F0-54C1-4991-8B11-188BFFA9A65BQ36807027-EEEAE351-E126-475C-BF0F-2B1E7CB99190Q38965204-BEA5670F-875F-4936-ACFC-ED5CC58A07AEQ40606151-51ED8CED-9106-4712-8C0E-EE6F85D85771Q43218265-45A39494-B832-4209-8E54-2EE7D509F1A8Q44563323-ABAF07D9-E59B-4C85-B3EE-C477EF726200Q54247889-DCF0E6A0-DE20-4CCB-B113-E948EC334EE3Q55016760-ECDECBC3-12DB-4EA1-92A8-51DB2E39043D
P2860
Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@ast
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@en
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@nl
type
label
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@ast
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@en
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@nl
prefLabel
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@ast
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@en
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@nl
P2093
P1476
Elevated glycine betaine excre ...... dysfunction and hyperglycemia
@en
P2093
P356
10.1016/S0168-8227(98)00115-6
P407
P577
1999-02-01T00:00:00Z